Lighting up targets of dual agonist therapies for diabetes and obesity
Crossref DOI link: https://doi.org/10.1038/s42255-025-01346-2
Published Online: 2025-08-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2025-08-19
Version of Record valid from 2025-08-19
Article History
First Online: 19 August 2025
